|
Growing food
Creating renewables
Supplying sustainably
Sustainability
Plant biotechnology stewardship
Crop protection stewardship
Benefits of plant science
Public health
Plant biotechnology
Biosafety Protocol
The Compact
Plant biotechnology stewardship
Benefits of plant biotechnology
Regulating plant biotechnology
Combined events
Discontinued products
Low level presence
Detection methods
Environmental risk assessment
Labelling
Co-existence: biotech, conventional, and organic
Intellectual property and plant biotechnology
Crop protection
Anti-counterfeiting
Intellectual property
International trade
|
|
Low level presence
Given the vast infrastructure dedicated to moving grain from farms to consumers around the world, the potential for the incidental commingling of products from different crops within grain, feed and food production is well recognised and taken into account by governments. This mixing of small amounts of other varieties is normally called adventitious presence: it is incidental but unavoidable. Some commingling is virtually guaranteed, even in the most stringent of identity preservation system. This applies equally to GM products that are authorised for use in a country of production (and potentially in other countries as well), but not yet approved in an importing country. International guidelines and/or practices that assist importing countries to assess the relative risks associated with the consumption of such technically unavoidable low levels of GM products will serve to assist trade, reduce administrative burdens, and reduce production costs. What is low level presence? What is the issue? AP is manageable
In addition, it is the policy and accepted best practice of the developers of GM plant varieties to seek authorisations in countries which import significant amounts of the crop in which a GM product has been introduced. The fact that authorisations are granted over different timescales is due to differences in the operation of different countries’ regulatory systems. International Guidance and/or Practices to address LLP is essential
As such, CropLife International has been lobbying for Codex Alimentarius’s Ad Hoc Intergovernmental Taskforce on Foods Derived from Biotechnology to include LLP on its work programme. This body has already developed internationally applicable principles for the risk analysis of foods derived from modern biotechnology and guidelines for the conduct of food safety assessment of foods derived from recombined- DNA plants. We believe that further work should now be undertaken to develop an international system to assess objectively the risks associated with the consumption of technically unavoidable low levels of plant material derived from GM crops not yet approved in all countries. AP and threshold costs Industry can implement different strategies and adopt various operational changes to reduce, but not eliminate, the likelihood of LLP. However, it must be born in mind that each intervention yields different probabilities of success and incurs additional costs as development, production, distribution and inventory expenditures rise, and as total supplies of marketable seeds are reduced. In fact, a survey of seed companies worldwide indicates that a company’s average per unit costs would increase by 7% at a 1% AP threshold. At a stricter 0.3% threshold, a company’s average per unit costs would go up by 28%.
News Release - CropLife Applauds Codex Commission on Finalizing International Low Level Presence Policy
(04/07/2008) CropLife International Executive Director for Plant Biotechnology Denise Dewar today issued the following statement on the forward movement of food safety guidelines for agricultural biotechnology by the Codex Commission in Geneva, Switzerland. Fact Sheet - Adventitious Presence or Low Level Presence (02/07/2008) Adventitious presence is an unavoidable reality of plant biology, seed production and distribution of commodity crops. Factors contributing to commingling: pollen flow; volunteerism; mixing, transport, storage and processing; human error; accidents. |
Last update: 31 Jul 2010
